In this episode, we hear from, Rich Brancaccio, Chief Innovation Officer of Revibe Technologies, and Lindsay Ayearst, Chief Scientific Officer of Revibe Technologies.

In their own words, Revibe is a digital therapeutics company fusing behavioral science with technology and currently developing a new digital therapy for ADHD.

In this episode, we cover:

Founding story and funding milestones
Child and caregiver experience using Revibe
Quantifying attention & capturing focus data
Evidence generation journey & clinical endpoints
The ADHD market choice to focus on adolescent ADHD
Lessons learned from the first wave of similar products and companies
OTC vs PDT

Guest Links and Resources:

Connect with Lindsay Ayearst on LinkedIn
Connect with Rich Brancaccio on LinkedIn
Visit www.revibetech.com

Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn
Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
Connect with YourCoach.health: Website | Twitter
Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Ep78: The Future of ADHD Treatment: Using a Digital Device to Re-Focus Attention

Powered by Wave AI